| 24 May 2026 |
Test Enanthate |
4.0 |
100mg/ml |
107.8mg/ml |
+7.8% |
96.37% |
Lab D |
| 24 May 2026 |
DNP |
4.0 |
50mg |
53.4mg |
+6.8% |
97.87% |
Lab G |
| 24 May 2026 |
Cartalax |
5.2 |
50mg |
55.8mg |
+11.6% |
99.85% |
Lab F |
| 23 May 2026 |
Crystagen |
5.0 |
5mg |
5.0mg |
-0.2% |
96.54% |
Lab A |
| 23 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
4.7 |
10mg |
10.4mg |
+4.0% |
95.55% |
Lab A |
| 23 May 2026 |
Epithalon |
4.0 |
5mg |
5.0mg |
+0.0% |
96.37% |
Lab D |
| 21 May 2026 |
Methylene Blue |
4.8 |
100mg |
93.1mg |
-6.9% |
95.75% |
Lab G |
| 21 May 2026 |
BMK glycidic acid (free acid) CAS 25547-51-7 |
7.2 |
1g |
1.2g |
+17.6% |
95.09% |
Lab C |
| 21 May 2026 |
Sildenafil Raw |
6.0 |
500g |
509.5g |
+1.9% |
97.84% |
Lab E |
| 20 May 2026 |
IGF-1 LR3 |
5.7 |
30mg |
32.4mg |
+8.1% |
98.91% |
Lab B |
| 20 May 2026 |
SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) |
4.0 |
100mg/ml |
120.9mg/ml |
+20.9% |
96.37% |
Lab E |
| 20 May 2026 |
Tesamorelin 11mg + Ipamorelin 6mg Blend |
4.0 |
5mg |
5.9mg |
+18.5% |
99.29% |
Lab E |
| 19 May 2026 |
NandroMix 300 |
10.0 |
250mg/ml |
282.4mg/ml |
+13.0% |
98.71% |
Lab D |
| 19 May 2026 |
VIP |
7.3 |
15mg |
15.2mg |
+1.2% |
99.28% |
Lab F |
| 17 May 2026 |
Adipotide |
4.0 |
20mg |
20.5mg |
+2.6% |
97.47% |
Lab C |
| 17 May 2026 |
Clenbuterol |
6.3 |
100mg |
116.5mg |
+16.5% |
98.36% |
Lab F |
| 17 May 2026 |
Trenbolone Enanthate Raw |
6.4 |
100g |
115.1g |
+15.1% |
96.28% |
Lab G |
| 29 Jan 2026 |
Retatrutide |
0.0 |
10mg |
⚠️ Sample does not contain Retatrutide ? |
(no batch ID) |
No Label / Red Crimp / Clear Cap |
|
| 29 Jan 2026 |
Tamoxifen (Nolvadex) |
5.2 |
100mg |
88.4mg |
-11.6% |
95.70% |
Lab F |
| 29 Jan 2026 |
Vilon |
4.0 |
30mg |
27.0mg |
-9.8% |
97.07% |
Lab G |
| 19 Jan 2026 |
Enclomiphene |
6.8 |
20mg |
23.1mg |
+15.5% |
95.66% |
Lab F |
| 7 Jan 2026 |
Orforglipron |
7.4 |
25mg |
28.3mg |
+13.3% |
96.45% |
Lab C |
| 7 Jan 2026 |
Pinealon |
4.8 |
50mg |
46.6mg |
-6.9% |
96.57% |
Lab C |
| 6 Jan 2026 |
AICAR |
6.8 |
2mg |
2.1mg |
+4.1% |
98.67% |
Lab G |
| 6 Jan 2026 |
Benzaldehyde CAS 100-52-7 |
5.5 |
100g |
102.5g |
+2.5% |
99.19% |
Lab C |
| 6 Jan 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
4.1 |
30mg |
27.4mg |
-8.8% |
96.00% |
Lab B |
| 6 Jan 2026 |
PTD-DBM |
4.1 |
10mg |
10.0mg |
-0.2% |
97.10% |
Lab D |
| 29 Dec 2025 |
Andarine (S-4) Raw |
4.0 |
100g |
106.6g |
+6.6% |
98.08% |
Lab A |
| 13 Dec 2025 |
Retatrutide |
7.2 |
20mg |
21.2mg |
+6.0% |
99.70% |
Lab G |
| 12 Dec 2025 |
Pancragen |
6.1 |
10mg |
9.9mg |
-1.5% |
96.89% |
Lab A |
| 23 Nov 2025 |
1-Testosterone Cypionate (DHB) Raw |
4.4 |
10g |
9.8g |
-1.8% |
99.73% |
Lab B |
| 23 Nov 2025 |
SR9009 |
5.1 |
100mg |
109.1mg |
+9.1% |
95.48% |
Lab C |
| 14 Nov 2025 |
GHRP-2 Acetate |
7.0 |
30mg |
29.4mg |
-2.1% |
95.26% |
Lab D |
| 5 Nov 2025 |
Cerebrolysin |
5.9 |
20mg |
17.1mg |
-14.4% |
97.75% |
Lab F |
| 5 Nov 2025 |
EPO |
4.0 |
30mg |
27.9mg |
-6.9% |
98.19% |
Lab E |
| 4 Nov 2025 |
Retatrutide |
7.4 |
5mg |
4.92mg |
-1.6% |
99.66% |
Lab E |
| 4 Nov 2025 |
FOXO4 |
4.4 |
20mg |
22.3mg |
+11.7% |
98.78% |
Lab F |
| 29 Oct 2025 |
Retatrutide |
4.3 |
5mg |
6.06mg |
+21.2% |
99.61% |
Lab E |
| 17 Oct 2025 |
Dianabol Oil |
5.6 |
100mg/ml |
98.4mg/ml |
-1.6% |
97.29% |
Lab F |
| 9 Oct 2025 |
4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 |
4.0 |
500g |
457.2g |
-8.6% |
97.15% |
Lab B |
| 9 Oct 2025 |
Ostarine (MK-2866) |
4.1 |
10mg |
10.2mg |
+1.6% |
98.19% |
Lab E |
| 3 Oct 2025 |
Masteron P (Drostanolone P) |
4.9 |
250mg/ml |
305.1mg/ml |
+22.0% |
99.95% |
Lab A |
| 3 Jun 2025 |
Retatrutide |
6.4 |
20mg |
22.1mg |
+10.5% |
99.98% |
Lab E |